2022 Hyundai Tucson Blue
1.6 L • 4 • 177 hp • 4×4 • AT
KM8JBCA10NU060203
Sales history: 1
Highlights
Condition
Not provided
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
1.6 L • 4 • 177 hp • 4×4 • AT
Odometer
60,600 mi ≈ 97,526 km
Primary damage
Side
Secondary damage
Front end
Docs
Salvage
Extra
Auction
VIN
KM8JBCA10NU060203
Lot number
51222394
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Birmingham, AL
Description
Fuel type
Hybrid
Body color
Blue
Body type
SUV
Trim
Blue
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Hyundai models
2022 Hyundai Tucson Blue • 1.6 L • 4 cyl • 177 hp • 4×4 • Automatic • Copart Lot: 51222394 • VIN: KM8JBCA10NU060203
Find out more about this 2022 Hyundai Tucson Blue, available at the Copart salvage car auction as lot 51222394 in Birmingham, AL. This car has Side main damage. It is listed with start condition code. Odometer shows 60,600 mi. This Blue Hyundai Tucson SUV is equipped with Hybrid 1.6 L engine, 4×4 drivetrain, Automatic transmission. Check the vehicle history report for KM8JBCA10NU060203 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
